Purpose Men affected by prostate cancer are a patient population in need of on-going
person-centred supportive care. Our aim was to synthesise current available evidence with …

Background Penile rehabilitation, defined as the use of any drug or device at or after radical
prostatectomy to maximize erectile function recovery, is commonly used for post …

Purpose: Data on the incidence, mortality and burden of prostate cancer as well as changing
trends are necessary to provide policy makers with the evidence needed to allocate …

Introduction Sexual dysfunction is common in patients after radical prostatectomy (RP) for
prostate cancer. Aim To provide the International Consultation for Sexual Medicine (ICSM) …

We recently reported stage I of a phase 1/2 clinical trial of cell therapy to treat postradical
prostatectomy erectile dysfunction (INSTIN, INtra-cavernous STem-cell INjection clinical trial …

Purpose Erectile dysfunction (ED) is one of the most prevalent male sexual dysfunctions. ED
has been in the past mistakenly considered a purely psycho-sexological symptom by …

Erectile dysfunction (ED) is an important cause of reduced quality of life for men and their
partners. Recent studies have found that cavernous nerve injury (CNI) during prostate …

Erectile dysfunction (ED) is a major adverse effect of radical prostatectomy (RP). We
conducted a randomized controlled trial to examine the efficacy of aerobic training (AT) …

Many therapies for erectile dysfunction (ED) after prostate cancer treatment improve erectile
firmness, yet, most couples stop using aids within 1–2 years. Patients and partners who …

Background It is generally assumed that if a man does not regain urinary continence or
erectile function within 12 mo of radical prostatectomy (RP), then the chance of subsequent …